- Natural-, Medical- , Computer Sciences, Technology
- Medicine
- Pharmacy
- Analysis of the Regulatory Requirements for Biosimilars in the EU
- Bookcover of Analysis of the Regulatory Requirements for Biosimilars in the EU
- Booktitle:
-
Analysis of the Regulatory Requirements for Biosimilars in the EU
A General Overview
AV Akademikerverlag (2016-06-14 )
eligible for voucher
- ISBN-13:
978-3-639-88881-2
- ISBN-10:
- 3639888812
- EAN:
- 9783639888812
- Book language:
- Blurb/Shorttext:
- A biosimilar is a biological medicinal product which is a copy of an original (innovator) product. The innovator product is often manufactured by a different company and after the patent of the innovator product expires a biosimilar can be registered in the European Union to a lower price than the innovator product. The first biosimilar in the European Union was registered in 2006 and was a Somatropin compound. Now are about 20 biosimilars registered in the European Union. Forecasts expect that there will be a huge amount of biosimilars pushing on the market in the near future and that will have a big influence on the industry.
- Publishing house:
- AV Akademikerverlag
- Website:
- http://www.akademikerverlag.de/
- By (author) :
- Kerstin Zörweg
- Number of pages:
- 68
- Published at:
- 2016-06-14
- Stock:
- Available
- Category:
- Pharmacy
- Price:
- 26.90 €
- Keywords:
- Biosimilars, Regulatory
